Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,373 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

for
Type III Achalasia,
Location: Chicago IL, Cleveland OH, Nashville TN, Atlanta GA,
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07293689

Recruiting

Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema

for
Pleural Infection Bacterial, Pleural Infections,
Location: Chicago IL, Detroit MI, Chapel Hill NC, New Haven CT,
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07095361

Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Chicago IL, Oak Lawn IL, Park Ridge IL, Elmhurst IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06410248

Phase1, Recruiting

FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial

for
Moderate to Severe Traumatic Brain Injury
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 65

Code: NCT06062888

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pupillometry in Delayed Sleep Wake Phase Disorder

for
Delayed Sleep-Wake Phase Disorder
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 16+

Code: NCT06949644

Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Chicago IL, Oak Park IL, Maywood IL, Elmhurst IL,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase3, Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Chicago IL, Maywood IL, Melrose Park IL, Carmel IN,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase3, Recruiting

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

for
Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS)
Location: Chicago IL, Boston MA, Aurora CO, Stanford CA,
Sponsor: Sonoma Biotherapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07123038

Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Chicago IL, Niles IL, Grand Rapids MI, Iowa City IA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Chicago IL, Oak Brook IL, Orland Park IL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06532279

Phase2, Recruiting

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Chicago IL, Oak Brook IL, Glenview IL, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase2, Recruiting

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

for
Kidney Disease, Peritoneal Dialysis (PD),
Location: Chicago IL, Augusta GA, Winnipeg, Victorville CA
Sponsor: Bodyport Inc.

Sex: All

Age: 21+

Code: NCT07059962

Recruiting

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

for
Pancreatic Carcinoma, Pancreatic Neoplasm
Location: Chicago IL, Marshfield WI, St Louis MO, Sunset Hills MO,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06807437

Phase3, Recruiting

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

for
Locally Advanced Differentiated Thyroid Gland Carcinoma,
Location: Chicago IL, Torrance CA
Sponsor: Jochen Lorch

Sex: All

Age: 18+

Code: NCT06959641

Phase2, Recruiting

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

for
Preterm Delivery, Obstetrical Complications
Location: Chicago IL, Columbus OH, Cleveland OH, Pittsburgh PA,
Sponsor: The George Washington University Biostatistics Center

Sex: Female

Age: 14+

Code: NCT06980025

Phase3, Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Chicago IL, Indianapolis IN, Ann Arbor MI, Columbus OH,
Sponsor: Intellia Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06128629

Phase3, Recruiting

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

for
Acute Pancreatitis
Location: Chicago IL, Indianapolis IN, Columbus OH,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06401577

Recruiting

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

for
NSCLC
Location: Chicago IL, Ann Arbor MI, Saint Louis MO, Columbus OH,
Sponsor: Lung Cancer Mutation Consortium

Sex: All

Age: 0+

Code: NCT04712877

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Chicago IL, Maywood IL, Oak Lawn IL, Evanston IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago